Two Sigma Advisers
TSVT

Two Sigma Advisers’s 2seventy bio TSVT Stock Holding History

Two Sigma Advisers’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,600
Closed -$77.1K – 2556
2025
Q1 		$77.1K Sell
15,600
-1,700
-10% -$5.4K ﹤0.01% 2274
2024
Q4 		$50.9K Buy
17,300
+2,100
+14% +$8.61K ﹤0.01% 2281
2024
Q3 		$71.7K Sell
15,200
-800
-5% -$3.61K ﹤0.01% 2194
2024
Q2 		$61.6K Buy
16,000
+1,400
+10% +$6.31K ﹤0.01% 2350
2024
Q1 		$78.1K Sell
14,600
-39,900
-73% -$188K ﹤0.01% 2320
2023
Q4 		$233K Buy
+54,500
New +$168K ﹤0.01% 2186

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Advisers's TSVT Position: Q2 2025 in Review

Two Sigma Advisers sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 15,600 shares — an estimated $77.1K sold.

Two Sigma Advisers first reported a position in TSVT in Q4 2023 and held it in 6 quarters. The position peaked at $233K in Q4 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Two Sigma Advisers reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 15,600 2seventy bio shares in Q2 2025, an estimated $77.1K.
  • Two Sigma Advisers first reported a position in 2seventy bio in Q4 2023 and held it in 6 quarters.
  • Two Sigma Advisers's 2seventy bio position peaked at $233K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.